Capital, LLC EcoR1, a director at $ZYME ($ZYME), bought 11,958 shares of the company on 12-24-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 0.1%. Following this trade, they now own 14,704,239 shares of $ZYME stock.
$ZYME Insider Trading Activity
$ZYME insiders have traded $ZYME stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ZYME stock by insiders over the last 6 months:
- CAPITAL, LLC ECOR1 has traded it 3 times. They made 3 purchases, buying 130,309 shares and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ZYME Hedge Fund Activity
We have seen 67 institutional investors add shares of $ZYME stock to their portfolio, and 94 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS ASSET MANAGEMENT AMERICAS LLC added 1,846,100 shares (+3279.0%) to their portfolio in Q2 2024
- BVF INC/IL removed 1,262,065 shares (-21.5%) from their portfolio in Q3 2024
- NEXTECH INVEST LTD. added 1,113,946 shares (+inf%) to their portfolio in Q3 2024
- MORGAN STANLEY added 867,422 shares (+20.5%) to their portfolio in Q3 2024
- DEUTSCHE BANK AG\ removed 829,266 shares (-35.2%) from their portfolio in Q3 2024
- CITADEL ADVISORS LLC removed 578,574 shares (-96.5%) from their portfolio in Q3 2024
- PERCEPTIVE ADVISORS LLC added 512,309 shares (+30.7%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
